Figitumumab (Anti-IGF1R / CD221)
Figitumumab (Anti-IGF1R / CD221) (A2942-GRP)
Products
Description
Figitumumab (Anti-IGF1R / CD221) is a human monoclonal antibody directed against the insulin-like growth factor type I receptor (IGF1R) with potential antineoplastic activity. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM. MW: 146.0 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2942 |
| Target | IGF-1R |